Key contacts

Will Corkill

Will Corkill
Director

Simon Wilson

Simon Wilson
Director

Regional office - Australia
Level 25
Aurora Place
88 Phillip Street
Sydney
NSW 2000
Australia
Tel: +61 (0)2 9258 1161

Regional office - New Zealand
Level 15
171 Featherston Street
Wellington 6011
New Zealand
Tel: +64 (0)4 8948555

swilson@edisongroup.com
wcorkill@edisongroup.com

listed companies

Range Resources Nkwe Platinum
MEC Resources Coal of Africa
Syndicated Metals Gold One
Bionomics Allied Gold Mining
Phylogica ADX Energy
Alkane Resources Bellzone Mining
Sumatra Copper & Gold Continental Coal
Gunson Resources RedFlow
Lochard Energy Circadian Technologies
Universal Coal Biotron
See more

Companies with HQs in asia-pacific

Seeing Machines Forterra Trust
Greka Drilling Bezant Resources
Green Dragon Gas Baobab Resources
Endace Wynnstay Group
PXP Vietnam Fund Chatham Rock Phosphate
Tenon MMG
SeaDragon Contact Energy
Cue Energy New Zealand Oil & Gas
Rubicon Sky Network Television
Sealegs Corporation Kreuz Holdings
See more

Latest research

Danakali

Maiden ore reserve underpins valuation upside

Update | Mining | 26/06/2015

Since the release of its PFS in February 2015, Danakali (DNK) has continued on its path towards production with the announcement of a maiden ore reserve of 1.1Bt, a successful A$6.1m equity raising, the appointment of a respected financial advisor to explore project funding options and achieved solid progress on the DFS.

Real Energy

Low-risk catalysts

QuickView | Oil & Gas | 24/06/2015

Real Energy’s principal focus is on developing unconventional and conventional gas and oil resources in the Cooper and Eromanga Basins in Central Australia. The Tamarama-1 and Queenscliff-1 wells were drilled on the ATP927P permit and confirmed a working basin-centred gas play. Post drill, Real estimates in excess of 1tcf of gas at the 3C level is present. The next steps are to independently confirm in-place volumes, progress gas take-off from LOI to firm contracts and establish full commerciality.

Simavita

Termination of coverage

Update | Pharmaceutical & Healthcare | 22/06/2015

Edison Investment Research is terminating coverage on Simavita (SV/SVA). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Novogen

Promising anti-cancer drugs head to the clinic

Initiation | Pharmaceutical & Healthcare | 22/06/2015

Novogen is developing two groups of anti-cancer compounds that have shown a great deal of promise in preclinical studies. Its super-benzopyran drugs are highly potent against cancer stem cells that are resistant to standard chemotherapy drugs, both in vitro and in animal models. Its lead anti-tropomyosin drug, Anisina, shows strong synergy with standard-ofcare anti-mitotic vinca alkaloid drugs. The company is well funded, having raised ~A$35m in the past two months, and is on track to have its three…

Pura Vida Energy

Reaction to drilling

Update | Oil & Gas | 22/06/2015

Since initiating on Pura Vida (PVD) on 26 May 2015, the company has commenced drilling of the MZ-1 well, offshore Morocco. Only three weeks into a minimum 60-day well, the stock has fallen by more than 30% and appears oversold on volatility driven without newsflow. Without doubt the MZ-1 is a high-risk well, but PVD is fully carried by an accomplished operator in Freeport that is currently executing a thorough and well-planned well. We maintain our RENAV of A$1.42/share.

About

Edison‘s Sydney and Wellington offices opened in 2011 to provide research services to companies listed on Asia-Pacific stock exchanges. Companies of all sizes benefit from our research service, which provides the highest standards of research and unrivalled distribution of our reports on a global and unrestricted basis.

Sector Commentary

See more reports See more reports See more reports

Sector Reports

See more sector reports See more sector reports